TCM
Tekla Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $35.6M | Buy |
657,790
+91,800
| +16% | +$4.97M | 1.39% | 18 |
|
|
2023
Q1 | $28.3M | Sell |
565,990
-191,025
| -25% | -$9.56M | 1.08% | 27 |
|
|
2022
Q4 | $35M | Sell |
757,015
-38,200
| -5% | -$1.77M | 1.32% | 22 |
|
|
2022
Q3 | $30.8M | Hold |
795,215
| – | – | 1.26% | 24 |
|
|
2022
Q2 | $29.6M | Buy |
795,215
+225,817
| +40% | +$8.42M | 1.16% | 24 |
|
|
2022
Q1 | $25.2M | Buy |
569,398
+33,356
| +6% | +$1.48M | 0.89% | 32 |
|
|
2021
Q4 | $22.8M | Buy |
536,042
+350,111
| +188% | +$14.9M | 0.73% | 39 |
|
|
2021
Q3 | $8.07M | Hold |
185,931
| – | – | 0.26% | 83 |
|
|
2021
Q2 | $7.95M | Hold |
185,931
| – | – | 0.26% | 97 |
|
|
2021
Q1 | $7.19M | Sell |
185,931
-60,158
| -24% | -$2.33M | 0.25% | 100 |
|
|
2020
Q4 | $8.85M | Sell |
246,089
-495,207
| -67% | -$17.8M | 0.31% | 89 |
|
|
2020
Q3 | $28.3M | Buy |
741,296
+96,361
| +15% | +$3.68M | 1.06% | 23 |
|
|
2020
Q2 | $22.6M | Buy |
644,935
+57,273
| +10% | +$2.01M | 0.86% | 27 |
|
|
2020
Q1 | $19.2M | Buy |
587,662
+23,317
| +4% | +$761K | 0.87% | 26 |
|
|
2019
Q4 | $25.5M | Sell |
564,345
-605
| -0.1% | -$27.4K | 0.97% | 24 |
|
|
2019
Q3 | $23M | Sell |
564,950
-67,300
| -11% | -$2.74M | 1% | 26 |
|
|
2019
Q2 | $27.2M | Buy |
632,250
+158,631
| +33% | +$6.82M | 1.11% | 23 |
|
|
2019
Q1 | $18.2M | Buy |
473,619
+28,628
| +6% | +$1.1M | 0.74% | 34 |
|
|
2018
Q4 | $15.7M | Hold |
444,991
| – | – | 0.67% | 35 |
|
|
2018
Q3 | $17.1M | Sell |
444,991
-12,594
| -3% | -$485K | 0.62% | 40 |
|
|
2018
Q2 | $15M | Hold |
457,585
| – | – | 0.57% | 41 |
|
|
2018
Q1 | $12.5M | Buy |
457,585
+192,985
| +73% | +$5.27M | 0.49% | 47 |
|
|
2017
Q4 | $6.56M | Buy |
+264,600
| New | +$6.56M | 0.25% | 74 |
|